Huons Meditech Launches DermaShine Duo RF to Advance Energy Based Aesthetic Devices Market

Huons Meditech Launched DermaShine Duo RF, Adding RF to its Injector Platform

This new product features low-output RF energy and precise drug delivery unified in a reticular-dermis dual layer and a single-handpiece tightening mechanism, shown with exploratory clinical and preclinical data. RF was integrated for the 25,000-unit DermaShine line, with Lincurve Pro and AestheFill Lux.

Huons Meditech has transformed from Boosting to Skin Rebooting

DermaShine Duo RF is a hybrid device, equipped with an electrically powered drug-delivery injector and radiofrequency (RF) in a single handpiece. For this purpose, Huons Meditech and Humedix organized lectures into three sessions, including skin volumizing, skin rejuvenation, and lifting.

This symposium highlighted the PDLLA skin booster AestheFill Lux, newly launched and distributed in Korea by Humedix. It has also introduced clinical strategies for the curved-cartridge HIFU device Lincurve Pro. The company presented DermaShine Duo RF as a device that combines the company's core competency in precise drug delivery and low-output RF lifting.

According to Precedence Research, the energy-based aesthetic devices market size was calculated at USD 8.35 billion in 2025 and is predicted to increase from USD 9.54 billion in 2026 to approximately USD 30.81 billion by 2035, expanding at a CAGR of 13.95% from 2026 to 2035, due to innovative platforms with precision across all skin types while lowering operator risk and multi-platform versatility.

Industry Impact and Market Outlook

The energy-based aesthetic devices market is dominated by the increased focus of companies on medical and cosmetic technology, driving technical innovations in body contouring, skin tightening, and hair removal. The top companies in this market are Cynosure Lutronic, Sisram Medical Ltd, Solta Medical, Candela Corporation, InMode Ltd., Lumenis Be Ltd, Cutera, Inc., Venus Concept Inc., AbbVie Inc., and Merz Pharma GmbH & Co. KGaA. The technological updates have led to multi-modal hybrid platforms, AI integration, and non-invasive alternative treatments. The leading manufacturers are expanding their catalogs with high-efficiency workstations to boost patient comfort and lower treatment times. The R&D spending has been seen in AI integration, smart diagnostic ecosystems, regulatory compliance frameworks, and combination and modular platforms.